Search Results
Dr Jennifer Brown on the Role of Genomic Sequencing in CLL
Jennifer R. Brown, MD, PhD: The Changing Definition of “High-Risk” CLL
Dr. Jennifer Brown on the Role of FCR in CLL
Sequencing of BTK inhibitors in CLL
Jennifer Brown, MD, PhD, Discusses Genomic Evolution of Pirtobrutinib Resistance
The BCR signaling pathway in CLL
ASH Impact Series: Jennifer Brown, MD, PhD - Treating High-Risk CLL
Dr. Jennifer Brown on Ibrutinib, Idelalisib, and Other Agents for CLL
CHC 2018: DR. Jennifer Brown - Relapsed CLL in 2018
Genomic evolution and resistance to pirtobrutinib in CLL: insights from the BRUIN study
Dr. Jennifer Brown on Duvelisib in CLL
Chronic Lymphocytic Leukemia: Sequencing Agents
